메뉴 건너뛰기




Volumn 20, Issue 7, 2005, Pages 1012-1015

Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine

Author keywords

Antisecretory efficacy; Cimetidine; Famotidine; pH monitoring

Indexed keywords

CIMETIDINE; FAMOTIDINE;

EID: 21844444142     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03917.x     Document Type: Article
Times cited : (12)

References (19)
  • 1
    • 0026596901 scopus 로고
    • Potent versus mild acid suppression in peptic ulcer disease
    • Howden CW. Potent versus mild acid suppression in peptic ulcer disease. Hepatogastroenteroly 1992; 39: 45-6.
    • (1992) Hepatogastroenteroly , vol.39 , pp. 45-46
    • Howden, C.W.1
  • 2
    • 0023617192 scopus 로고
    • Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
    • Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.
    • (1987) Gut , vol.28 , pp. 1120-1127
    • Jones, D.B.1    Howden, C.W.2    Burget, D.W.3    Kerr, G.D.4    Hunt, R.H.5
  • 3
    • 0032976315 scopus 로고    scopus 로고
    • Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
    • DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol. 1999; 94: 1434-42.
    • (1999) Am. J. Gastroenterol. , vol.94 , pp. 1434-1442
    • Devault, K.R.1    Castell, D.O.2
  • 4
    • 0028890445 scopus 로고
    • Optimizing acid suppression for treatment of acid-related diseases
    • Hunt RH, Cederberg C, Dent J et al. Optimizing acid suppression for treatment of acid-related diseases. Dig. Dis. Sci. 1995; 40 (Suppl. 2): 24-49.
    • (1995) Dig. Dis. Sci. , vol.40 , Issue.SUPPL. 2 , pp. 24-49
    • Hunt, R.H.1    Cederberg, C.2    Dent, J.3
  • 5
    • 0026803020 scopus 로고
    • Appropriate acid suppression for the management of gastro-oesophageal reflux disease
    • Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 59-67.
    • (1992) Digestion , vol.51 , Issue.SUPPL. 1 , pp. 59-67
    • Bell, N.J.1    Burget, D.2    Howden, C.W.3    Wilkinson, J.4    Hunt, R.H.5
  • 6
    • 0028243453 scopus 로고
    • Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole
    • Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment. Pharmacol. Ther. 1994; 8: 193-201.
    • (1994) Aliment. Pharmacol. Ther. , vol.8 , pp. 193-201
    • Hurlimann, S.1    Abbuhl, B.2    Inauen, W.3    Halter, F.4
  • 7
    • 10744228067 scopus 로고    scopus 로고
    • The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH
    • Abe Y, Inamori M, Togawa J et al. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J. Gastroenterol. 2004; 39: 21-5.
    • (2004) J. Gastroenterol. , vol.39 , pp. 21-25
    • Abe, Y.1    Inamori, M.2    Togawa, J.3
  • 8
    • 0033458763 scopus 로고    scopus 로고
    • Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis
    • Jansen JB, Van Oene JC. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. Aliment. Pharmacol. Ther. 1999; 13: 1611-20.
    • (1999) Aliment. Pharmacol. Ther. , vol.13 , pp. 1611-1620
    • Jansen, J.B.1    Van Oene, J.C.2
  • 9
    • 0029986784 scopus 로고    scopus 로고
    • The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH
    • Chassany O, Bergmann JF, Simoneau G, Elouaer-Blanc L, Segrestaa JM, Caulin C. The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH. Curr. Ther. Res. 1996; 57: 159-67.
    • (1996) Curr. Ther. Res. , vol.57 , pp. 159-167
    • Chassany, O.1    Bergmann, J.F.2    Simoneau, G.3    Elouaer-Blanc, L.4    Segrestaa, J.M.5    Caulin, C.6
  • 10
    • 0026612823 scopus 로고
    • Does H2 receptor antagonist-resistant ulcer exist? A review based on bioavailability in man
    • Kawai K. Does H2 receptor antagonist-resistant ulcer exist? A review based on bioavailability in man. Gastroenterol. Jpn 1992; 27: 418-23.
    • (1992) Gastroenterol. Jpn. , vol.27 , pp. 418-423
    • Kawai, K.1
  • 11
    • 0037300057 scopus 로고    scopus 로고
    • Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection
    • Adachi K, Fujishiro H, Mihara T, Komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J. Gastroenterol Hepatol 2003; 18: 168-71.
    • (2003) J. Gastroenterol. Hepatol. , vol.18 , pp. 168-171
    • Adachi, K.1    Fujishiro, H.2    Mihara, T.3    Komazawa, Y.4    Kinoshita, Y.5
  • 12
    • 0036709389 scopus 로고    scopus 로고
    • Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection
    • Adachi K, Kawamura A, Ono M et al. Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J. Gastroenterol 2002; 37: 703-8.
    • (2002) J. Gastroenterol. , vol.37 , pp. 703-708
    • Adachi, K.1    Kawamura, A.2    Ono, M.3
  • 13
    • 0038727629 scopus 로고    scopus 로고
    • Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection
    • Komazawa Y, Adachi K, Mihara T et al. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2003; 18: 678-82.
    • (2003) J. Gastroenterol. Hepatol. , vol.18 , pp. 678-682
    • Komazawa, Y.1    Adachi, K.2    Mihara, T.3
  • 14
    • 0029157168 scopus 로고
    • Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists
    • Katsu K, Yabe S. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists. Clin. Ther. 1995; 17: 433-40.
    • (1995) Clin. Ther. , vol.17 , pp. 433-440
    • Katsu, K.1    Yabe, S.2
  • 15
    • 0028915876 scopus 로고
    • Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole
    • Verdu EF, Armstrong D, Fraser R et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
    • (1995) Gut , vol.36 , pp. 539-543
    • Verdu, E.F.1    Armstrong, D.2    Fraser, R.3
  • 16
    • 0029047385 scopus 로고
    • Review article: The development of atrophic gastritis-Helicobacter pylori and the effects of acid suppressive therapy
    • Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SG. Review article: the development of atrophic gastritis-Helicobacter pylori and the effects of acid suppressive therapy. Aliment. Pharmacol. Ther. 1995; 9: 331-40.
    • (1995) Aliment. Pharmacol. Ther. , vol.9 , pp. 331-340
    • Kuipers, E.J.1    Lee, A.2    Klinkenberg-Knol, E.C.3    Meuwissen, S.G.4
  • 17
    • 0033023098 scopus 로고    scopus 로고
    • Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
    • Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999; 117: 11-16.
    • (1999) Gastroenterology , vol.117 , pp. 11-16
    • Holtmann, G.1    Cain, C.2    Malfertheiner, P.3
  • 18
    • 0033859704 scopus 로고    scopus 로고
    • Helicobacter pylori infection influences nocturnal gastric acid breakthrough
    • Katsube T, Adachi K, Kawamura A et al. Helicobacter pylori infection influences nocturnal gastric acid breakthrough. Aliment. Pharmacol Ther. 2000; 14: 1049-56.
    • (2000) Aliment. Pharmacol Ther. , vol.14 , pp. 1049-1056
    • Katsube, T.1    Adachi, K.2    Kawamura, A.3
  • 19
    • 0032763735 scopus 로고    scopus 로고
    • Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis
    • Koike T, Ohara S, Sekine H et al Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am. J. Gastroenterol 1999; 94: 3468-72.
    • (1999) Am. J. Gastroenterol. , vol.94 , pp. 3468-3472
    • Koike, T.1    Ohara, S.2    Sekine, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.